ReviewFrontiers in immunology2024

Tumor-derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer.

Yunjiao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.